7.04
-0.57(-7.49%)
Currency In USD
Address
Building 4
Palo Alto, CA 94306
United States of America
Phone
650 507 0669
Website
Sector
Healthcare
Industry
Biotechnology
Employees
4
First IPO Date
June 27, 2017
| Name | Title | Pay | Year Born |
| Mr. Lloyd Blair Jordan L.L.B., M.B.A. | Chief Executive Officer & Director | 211,982 | 1970 |
| Dr. Lawrence Steinman BA, M.D., Ph.D. | Co-Founder & Director | 30,000 | 1948 |
| Sir Marc Feldman Ph.D. | Co-Founder | 130,062 | 1945 |
| Mr. Eric R. Van Lent | CAO, Principal Accounting & Financial Officer | 0 | 1983 |
| Prof. Jagdeep Nanchahal M.D., Ph.D. | Co-Founder & Chairman of Clinical Advisory Board | 0 | N/A |
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.